Clinical Trial Update: Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating the efficacy of sirolimus in liver transplantation for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED